Introduction
Heart failure (HF) is a life-limiting disease that affects approximately 5.7 million people in the United States and is listed as a cause of death on one in nine death certificates [1] . Despite considerable advances in medical therapies, prognosis in HF remains poor, with 5-year mortality for patients with symptomatic HF estimated at 50% [2] . Hospitalization portends a poor outcome in HF, with 17-36% of patients dying within one year of HF hospitalization [3] [4] [5] . Furthermore, end-stage HF is characterized by frequent hospitalizations and readmissions, with estimates of 30-day readmission rates ranging from 11% to 25% [6] [7] [8] [9] [10] . This has a significant impact on both patient quality of life as well as healthcare expenditures [11] . Original Article integration of palliative care (PC) services has been recommended by several major societies for the care of advanced HF patients [2, [12] [13] [14] [15] . PC has been shown to improve outcomes in HF; however, recent studies show that uptake of PC in this population is still low [16] [17] [18] [19] .
Inpatient PC consultation has been shown to decrease 30-day readmission rates in mixed patient populations [20] [21] [22] [23] . However, two recent single-centre studies have not upheld this relationship in the HF population, and there remains clinical equipoise this area [24, 25] . Given the prevalence of HF, the recognized high readmission rates for HF patients, and the associated costs of hospitalization, an intervention to decrease readmission rates could have a significant impact on healthcare utilization and costs.
The objective of our study was to use a large national database to examine the relationship between inpatient PC visits during hospitalization for HF and 9-month readmission rates. We hypothesized that inpatient PC visits would decrease readmission rates in patients admitted to hospital with HF.
Methods
Our results are published in accordance with STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement [26] . We used the Nationwide Readmission Database (NRD) for this analysis. The NRD, produced by the Agency for Healthcare Quality and Research (AHRQ), gathers longitudinal data for patients from 22 states and is powered to produce national projections using a complex survey design. Unique patients are tracked throughout the sample year, and all admissions to acute-care hospitals are linked for analysis. As the NRD is an amalgamation of state inpatient databases, out-of-state hospital admissions are not captured. Further information on the structure and sampling frame of the NRD is available from the AHRQ.
A waiver of consent was obtained for the use of this de-identified dataset by the Institutional Review Board of the University of British Columbia. The primary outcome for this study was the 9-month rate of readmission to hospital for any reason. The secondary outcomes were the 9-month rate of readmission for a HF exacerbation as well as average hospital charges per patient for the 9-month follow-up period.
Cohort selection
All patients aged ≥18 years who were admitted with a primary diagnosis of HF (International Classification of Disease 9th edition (ICD9) code 428.xx) in the first 3 months of 2013 were isolated from the NRD. Patients who underwent left ventricular assist device implantation (37.52, 37.60) or cardiac transplantation (37.51) were excluded from the analysis. Patients who survived the index hospital admission were included in the final cohort. The cohort was then segregated into patients who received an inpatient PC visit (V667) and those who did not during the index admission. The code for a PC visit has been validated to have a sensitivity of 81% and a specificity of 97% in a population of stroke patients [27] . Unfortunately, this code has not been specifically validated in a HF population.
The original cohort was tracked for 9 months following the index admission time period. A hospital admission for any reason in the 9-month follow-up period was considered a readmission. We also isolated admissions for a primary diagnosis of HF (428.xx) during the follow-up period as a secondary end-point. Patients admitted in the early part of the index period were followed for longer than 9 months, as any admission during the remaining time in the index period was included as a readmission. A patient selection flow chart diagram is displayed in Fig. 1 .
From the database we collected the following patient-level variables: age, gender, insurance coverage (yes versus no), hospital length of stay, inhospital mortality, total hospital charges and discharge location (home, skilled nursing facility, home care/hospice, or other). We obtained the presence of the 29 Elixhauser Co-Morbidity indices for all patients [28] . The presence of Do Not Resuscitate Status was collected using ICD9 code V4986. The treating hospital's teaching status was also obtained.
Statistical analysis
Complex survey techniques in SAS v9.4 (SAS Institute, Cary, NC, USA) were employed throughout the analysis to preserve the integrity of the NRD. All statistical tests were conducted with a two-sided alpha level of 0.05 and, where appropriate, 95% confidence intervals are displayed. For analysis of continuous data, independent t-tests or Wilcoxon Rank Sum tests were utilized depending on the normality of the data. Categorical data were analysed using chi-squared testing.
A multivariate logistic regression model was created to predict the result of hospital readmission for HF. All variables were chosen a priori and included age, gender, insurance coverage, discharge location from index hospitalization, DNR status, PC visit at index hospitalization and the 28 Elixhauser co-morbidity indices. The HF Elixhauser variable was not used in the analysis as all patients in the study had a diagnosis of HF. The C-statistic for the model predicting readmission to hospital was 0.64.
To strengthen the association between PC referral and HF readmission, a propensity score for the intervention of PC referral was created. Factors included in the model were age, gender, DNR status, insurance coverage, as well as the 28 Elixhauser co-morbidity indices. The C-statistic for the logistic regression model predicting the probability of PC referral was 0.84.
Results
A total of 14 325 172 hospital admissions were contained in the 2013 sample of the NRD. There were 102 746 patients who survived an admission for HF in the first 3 months of 2013. Of these, 2287 (2.2%) patients had PC visits as inpatients. Of the 100 459 patients who did not have PC visits, 60 170 (59.8%) had a readmission within 9 months, with 28 197 (28.0%) of these admissions being for HF. In contrast, of the patients with PC visits, 526 (21.8%) had a readmission within 9 months, with 226 (9.3%) of these being for HF (P < 0.01). Numerous patients suffered repeat readmissions, the total number of readmissions in the non-PC cohort was 140 955 (2.34 admissions per patient), whilst there was a total of 981 (1.8 admissions per patient, P < 0.01) readmissions in the entire PC cohort (nonpropensity matched).
Patient characteristics
Patients with PC visits were older (80.9 years SD 11.1 vs. 72.7 years SD 14.1, P < 0.01), more likely to be female (54.0% vs. 48.6%, P < 0.01), and had longer hospitalizations than those not referred to PC (5.1 days IQR 2.9-8.7 vs. 3.5 days IQR 2.0-5.9, P < 0.01, Table 1 ). PC patients were also more likely to be discharged to Home Care / Hospice Care (41.4% vs. 25.4%) and skilled nursing facilities (44.5% vs. 19.5%, P < 0.01).
Evidence that PC causally contributed
The results of the multivariate analysis modelling 9-month all-cause hospital readmission are displayed in Table 2 . Palliative care visit was associated with significantly reduced risk of readmission (OR 0.23, 95% CI 0.20-0.25, P < 0.01). Patients with insurance coverage (OR 1.47, 95% CI 1.39-1.56, P < 0.01), as well as female patients (OR 1.06, 95% CI 1.03-1.09, P < 0.01), were more likely to be readmitted. Discharge from the original hospitalization to a skilled nursing facility (OR 1.13, 95% CI 1.09-1.17, P < 0.01), hospice care/home care (OR 1.23, 95% CI 1.20-1.27, P < 0.01) or other location (OR 1.11, 95% CI 1.02-1.21, P = 0.02) compared to being discharged home was also strongly associated with higher readmission rates. The Elixhauser comorbidities associated with readmission are displayed in Table S1 .
After matching based on propensity for PC visit during the index hospitalization, 2282 patients who received a PC visit were matched to 2282 patients who did not (Table 1) . Those receiving a PC visit were less likely to be readmitted for HF (9.3% vs. 22.4%, P < 0.01) or for any cause (29.0% vs. 63.2%, P < 0.01) during the 9-month follow-up period.
Cost analysis
The total hospital charges for all inpatient care during the follow-up period for the cohort without PC were $7.8 billion USD, representing an average charge per patient of $77 643 USD. The total charges for inpatient care during the 9-month follow-up period for the PC patients were $53 million USD, which was an average charge per patient of $23 200 USD (P < 0.01).
Discussion
In this large, nationally representative database analysis, inpatient PC visit during hospital admission for HF was associated with decreased 9-month readmission rates. This is consistent with existing literature demonstrating decreased readmission rates in patients receiving inpatient PC involvement [20] [21] [22] [23] . The large number of patients readmitted for HF is consistent with data from a recent large database-driven study from Dharamajan et al., who found that 35.2% of 30-day readmissions following a HF hospitalization were for the same diagnosis [7] .
In contrast to our findings, two previous singlecentre studies had not shown an association between PC visits and decreased readmission rates in HF. A recent retrospective single-centre trial failed to show a reduction in 30-day readmission in heart failure patients who had received a complete PC consultation in hospital [24] . However, the authors note that a subgroup analysis suggested that residual confounding may have obscured a possible difference between the two groups. In addition, a randomized trial of HF patients found no difference in readmission rates between patients randomized to inpatient PC consult versus regular care [25] . Importantly, however, in this study, advanced care planning (ACP) was included in the standard of care for both groups and was not further explored during PC consultation. This may be significant, as prior work has suggested that PC consultations focused solely on symptom control did not reduce readmissions, in contrast to those focused on ACP [20] . Whilst we were not able to capture the focus of PC visits in our study, this should be a point of interest for future research, given that prior work has shown that most existing PC pathways in HF focus heavily on symptom control, rather than on ACP [29] .
In our study, other factors associated with lower 9-month readmission rates included lack of insurance coverage, DNR status and discharge home (compared to discharge to hospice or to a skilled nursing facility). Previous work has identified, amongst other factors, nonwhite race, prior hospitalizations, increased length of stay and comorbid cardiac or systemic disease, and HF severity as factors associated with higher readmission rates [30] . Notably in the present study, the influence of PC on readmission remained significant whilst controlling for many of these factors, suggesting a robust role for inpatient PC in reducing readmission in HF.
In our study, inpatient PC visit was associated with decreased hospital-related healthcare costs. This is consistent with prior work on the economic impact of PC, which has been shown to decrease total healthcare expenditures by 9-25% [31] . Mechanisms by which PC reduces healthcare costs include decreased readmissions, fewer ICU and total hospital days, and fewer aggressive lifesustaining procedures [21, 31, 32] . The role of ACP in PC consultation is important, as patients with a terminal disease who receive ACP have lower healthcare expenditures in the last weeks of their life [33] . Specifically in HF, Cassels and colleagues recently reported that the implementation of a multipronged, PC-focused "Transitions" program resulted in healthcare savings of $3447 per month per patient [34] . This was similar to our findings of a savings of approximately $6000 in hospital charges per month of follow-up. However, a major limitation of our work, and the work of many others, was the inability to capture costs associated with home care, skilled nursing facilities and hospice care that may have been increased in the PC population. Our findings must, therefore, be interpreted with significant caution as we were unable to capture the overall economic impact of PC visits [17, 31] . Whilst further work is needed to clarify the financial effects of more widespread PC programs, there appears to be potential to reduce the high costs associated with end-stage HF.
The strength of this study lies primarily in its size and generalizability. By including patients from 22 states and capturing all types and sizes of hospitals, our data have excellent generalizability and build on work done in single-centre studies. The ability to track a large number of patients over time allowed us to investigate the impact of inpatient PC visits on longer-term patient outcomes.
This study has numerous limitations and must be interpreted in the context of its design. The most significant limitation of our study was our inability to control for mortality. We are, therefore, unable to elucidate the mechanisms by which PC reduces hospital readmission. It may be that PC visits lead to improved symptom control, increased community supports and clearer advanced care directives; and that this in turn leads to decreased hospital admissions. However, it is also possible that the PC cohort experienced higher mortality rates, which resulted in lower apparent readmission rates. Whilst we attempted to use a propensity score model to match patients between the PC and non-PC groups, PC involvement was not randomized, and therefore, a significant selection bias is possible. Given the nature of PC, it is likely that patients receiving PC had more severe illness at baseline, and their decreased readmission rates may be at least partly attributable to higher mortality rates as a result of end-stage disease. Further prospective work would be ideal to obtain an accurate representation of the effect of PC on overall health trajectory and mortality rates in this population.
A second limitation was our ability to accurately capture PC involvement. Retrospective, databasedriven studies are inherently susceptible to coding error and bias. In our study in particular, the use of the V667 code to identify a PC visit has not been validated in HF. Recent work by Hua et al. found that, in a single centre, sensitivity and specificity of the V667 code for detecting a PC visit were 49.9% and 99.1%, respectively [35] . This suggests that the code likely underestimates the true incidence of PC involvement. Furthermore, we were unable to capture community PC involvement in this study. It is possible, therefore, that some patients in our non-PC cohort may in fact have had contact with PC providers, which may have affected readmission rates in this group.
Thirdly, we were limited by our inability to record the nature of the PC visit, particularly given the suggestion that advanced care planning, rather than symptom-focused PC, results in lower readmission rates.
Finally, due to nature of the information captured by the NIS, we were unable to extract data on HF severity such as stage, NYHA class or ejection fraction. These factors have a significant impact on readmission risk, with patients with more advanced HF being at higher risk of readmission [36, 37] . Future studies using more granular clinical data will be important in defining the subset of patients who may benefit most from inpatient PC visits.
Conclusion
In this nationwide analysis, inpatient PC visit during an admission for HF was associated with significantly less all-cause readmissions as well as HF-specific readmissions in the subsequent 9 months. The average inpatient hospital charges for the 9-month follow-up period were also significantly lower in patients with PC visits. Further research is needed to better characterize the subset of HF patients in whom inpatient PC offers the most benefit.
